Vaporized medicants and methods of use
US10918684B2 · kind B2 · utility
0Cited by
13References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2018 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Jan 14, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and formulation for delivering a PDE-5 inhibitor in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the PDE-5 inhibitor. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol, vegetable glycerin and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.